Literature DB >> 20545708

Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines.

A Vazquez-Tello1, A Semlali, J Chakir, J G Martin, D Y Leung, D H Eidelman, Q Hamid.   

Abstract

BACKGROUND: Corticosteroid insensitivity in asthmatics is associated with an increased expression of glucocorticoid receptor-beta (GR-beta) in many cell types. T-helper type 17 (Th17) cytokine (IL-17A and F) expressions increase in mild and in difficult-to-treat asthma. We hypothesize that IL-17A and F cytokines alone or in combination, induce the expression of GR-beta in bronchial epithelial cells.
OBJECTIVES: To confirm the expression of the GR-beta and IL-17 cytokines in the airways of normal subjects and mild asthmatics and to examine the effect of cytokines IL-17A and F on the expression of GR-beta in bronchial epithelial cells obtained from normal subjects and asthmatic patients.
METHODS: The expression of IL-17A and F, GR-alpha and GR-beta was analysed in bronchial biopsies from mild asthmatics and normal subjects by Q-RT-PCR. Immunohistochemistry for IL-17 and GR-beta was performed in bronchial biopsies from normal and asthmatic subjects. The expression of IL-6 in response to IL-17A and F and dexamethasone was determined by Q-RT-PCR using primary airway epithelial cells from normal and asthmatic subjects.
RESULTS: We detected significantly higher levels of IL-17A mRNA expression in the bronchial biopsies from mild asthmatics, compared with normal. GR-alpha expression was significantly lower in the biopsies from asthmatics compared with controls. The expression of IL-17F and GR-beta in biopsies from asthmatics was not significantly different from that of controls. Using primary epithelial cells isolated from normal subjects and asthmatics, we found an increased expression of GR-beta in response to IL-17A and F in the cells from asthmatics (P< or =0.05). This effect was only partially significant in the normal cells. Dexamethasone significantly decreased the IL-17-induced IL-6 expression in cells from normal individuals but not in those from asthmatics (P< or =0.05).
CONCLUSION: Evidence of an increased GR-beta expression in epithelial cells following IL-17 stimulation suggests a possible role for Th17-associated cytokines in the mechanism of steroid hypo-responsiveness in asthmatic subjects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20545708     DOI: 10.1111/j.1365-2222.2010.03544.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  40 in total

Review 1.  Deciphering the role of Th17 cells in human disease.

Authors:  Cailin Moira Wilke; Keith Bishop; David Fox; Weiping Zou
Journal:  Trends Immunol       Date:  2011-09-28       Impact factor: 16.687

2.  Azelastine enhances the clinical efficacy of glucocorticoid by modulating MKP-1 expression in allergic rhinitis.

Authors:  Xi Luo; Renqiang Ma; Xingmei Wu; Desheng Xian; Jian Li; Zhonglin Mou; Huabin Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-25       Impact factor: 2.503

3.  Potential Role of Mast Cells in Regulating Corticosteroid Insensitivity in Severe Asthma.

Authors:  Abdulrahman Alzahrani; Aamir Hussain; Fahad Alhadian; Jameel Hakeem; Sana Douaoui; Omar Tliba; Peter Bradding; Yassine Amrani
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Pharmacological approaches to regulate neutrophil activity.

Authors:  G R Tintinger; R Anderson; C Feldman
Journal:  Semin Immunopathol       Date:  2013-03-15       Impact factor: 9.623

Review 5.  Role of dendritic cells: a step forward for the hygiene hypothesis.

Authors:  Xi Yang; Xiaoling Gao
Journal:  Cell Mol Immunol       Date:  2010-11-08       Impact factor: 11.530

6.  Evidence for a glucocorticoid receptor beta splice variant in the rat and its physiological regulation in liver.

Authors:  Debra C DuBois; Siddharth Sukumaran; William J Jusko; Richard R Almon
Journal:  Steroids       Date:  2012-12-19       Impact factor: 2.668

7.  Combined administration of anti-IL-13 and anti-IL-17A at individually sub-therapeutic doses limits asthma-like symptoms in a mouse model of Th2/Th17 high asthma.

Authors:  Dasom Kim; Jaclyn W McAlees; Lindsay J Bischoff; Davinder Kaur; Lauren K Houshel; Jerilyn Gray; Julie Hargis; Xenia Davis; Paul L Dudas; Hitesh Deshmukh; Ian P Lewkowich
Journal:  Clin Exp Allergy       Date:  2018-11-29       Impact factor: 5.018

8.  Targeting the phosphorylation site of myristoylated alanine-rich C kinase substrate alleviates symptoms in a murine model of steroid-resistant asthma.

Authors:  Chien-Neng Wang; Yu-Chao Lin; Bo-Chun Chang; Ching-Hsien Chen; Reen Wu; Chen-Chen Lee
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

9.  IL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors.

Authors:  Mushtaq Ahmed; Sarah L Gaffen
Journal:  Cytokine       Date:  2013-01-16       Impact factor: 3.861

10.  Interleukin-1 receptor and caspase-1 are required for the Th17 response in nitrogen dioxide-promoted allergic airway disease.

Authors:  Rebecca A Martin; Jennifer L Ather; Lennart K A Lundblad; Benjamin T Suratt; Jonathan E Boyson; Ralph C Budd; John F Alcorn; Richard A Flavell; Stephanie C Eisenbarth; Matthew E Poynter
Journal:  Am J Respir Cell Mol Biol       Date:  2013-05       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.